Showing results (71-80 of 447) with videos related to
Sort By:
Pageof 45
Circulation|September 1, 1995
Nifedipine. Dose-related increase in mortality in patients with coronary heart diseaseC D Furberg, B M Psaty, J V MeyerHypertension (Dallas, Tex. : 1979)|May 1, 1989
Controlled clinical trials of drug treatment for hypertension. A reviewJ A Cutler, S W MacMahon, C D FurbergUltrasound in Medicine & Biology|January 1, 1996
Assessment of temporal bias in longitudinal measurements of carotid intimal-medial thickness in the Asymptomatic Carotid Artery Progression Study (ACAPS). ACAPS Research GroupW A Riley, T Craven, A Romont, et al.The American Journal of Cardiology|June 1, 1990
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experienceR P Byington, J Worthy, T Craven, et al.Journal of Internal Medicine|May 1, 1994
Overtreatment and undertreatment of hypertensionC D Furberg, G Berglund, T A Manolio, et al.American Journal of Hypertension|June 20, 1998
Cost-minimization and the number needed to treat in uncomplicated hypertensionK A Pearce, C D Furberg, B M Psaty, et al.BMJ (Clinical Research Ed.)|April 7, 1990
Long term propranolol treatment and changes in body weight after myocardial infarctionS Rössner, C L Taylor, R P Byington, et al.Annals of Internal Medicine|December 19, 2001
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of HypertensionC D Furberg, B M Psaty, M Pahor, et al.Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapyH Sinzinger, G Lupattelli, F Chehne, et al.Current Hypertension Reports|May 17, 2001
Aldosterone antagonists in the treatment of hypertension and target organ damageS Rajagopalan, B PittPageof 45